FDA’s Conditional Approval Plan Would Unleash Biotech Innovation

forbes.com/sites/greglicholai/2025/05/05/fdas-conditional-approval-plan-would-unleash-biotech-innovation

In a move that could dramatically reshape the landscape for rare disease treatments, FDA Commissioner Marty Makary announced plans for conditional approval pathways

This story appeared on forbes.com, 2025-05-05 12:00:00.
The Entire Business World on a Single Page. Free to Use →